Professor | Tingting Li | Asia Growth Partners

Name	Tingting Li
Contact Information	tingtingli1191@cqmu.edu.cn
Language ability	Chinese, English
Province	Chongqing

Name

Tingting Li

Contact Information

tingtingli1191@cqmu.edu.cn

Language ability

Chinese, English

Province

Chongqing

University/Lab Affiliation and Title	Chongqing Medical University
Faculty	Basic Medical Sciences
Academic Background & Achievements	2010-2014 Bachelor: Harbin Medical University, Basic Medicine 2014-2015 Master: Harbin Medical University, Basic Medicine 2015-2018 Doctorate: Harbin Medical University, Pharmacology 2019-2021 Postdoctoral: Chongqing Medical University, Basic Medicine
Work Experience	2019-present - Chongqing Medical University - Associate Researcher in Immunology
Awards	2021: Chongqing Public Institution Staff Award 2022: Chongqing Public Institution Staff Award

University/Lab Affiliation and Title

Chongqing Medical University

Faculty

Basic Medical Sciences

Academic Background & Achievements

2010-2014 Bachelor: Harbin Medical University, Basic Medicine
2014-2015 Master: Harbin Medical University, Basic Medicine
2015-2018 Doctorate: Harbin Medical University, Pharmacology
2019-2021 Postdoctoral: Chongqing Medical University, Basic Medicine

Work Experience

2019-present - Chongqing Medical University - Associate Researcher in Immunology

Awards

2021: Chongqing Public Institution Staff Award
2022: Chongqing Public Institution Staff Award

Areas of Focus	Antibody Engineering and B Cell Function
Publications	Potent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants, Li T., Han X., Gu C., Guo H., Zhang H., Wang Y., Hu C., Wang K., Liu F., Luo F., Zhang Y., Hu J., Wang W., Li S., Hao Y., Shen M., Huang J., Long Y., Song S., Wu R., Mu S., Chen Q., Gao F., Wang J., Long S., Li L., Wu Y., Gao Y., Xu W., Cai X., Qu D., Zhang Z., Zhang H., Li N., Gao Q., Zhang G., He C., Wang W., Ji X., Tang N., Yuan Z., Xie Y., Yang H., Zhang B., Huang A., Jin A., 2021 A potent neutralizing antibody provides protection against SARS-CoV-2 Omicron and Delta variants via nasal delivery, Zhang X., Zhang H., Li T., Chen S., Luo F., Zhou J., Zheng P., Song S., Wu Y., Jin T., Tang N., Jin A., Yang C., Cheng G., Gong R., Chiu S., Huang A., 2022 Structures of Omicron spike complexes and implications for neutralizing antibody development, Guo H., Gao Y., Li T., Li T., Lu Y., Zheng L., Liu Y., Yang T., Luo F., Song S., Wang W., Yang X., Nguyen H.C., Zhang H., Huang A., Jin A., Yang H., Rao Z., Ji X., 2022 A non-RBM targeted RBD specific antibody neutralizes SARS-CoV-2 inducing S1 shedding, Long Y., Song S., Luo F., Han X., Hu C., Wang Y., Li S., Wang W., Zhang H., Zhang B., Li T., Jin A., 2021 Silencing of METTL3 attenuates cardiac fibrosis induced by myocardial infarction via inhibiting the activation of cardiac fibroblasts, Li, T., Y. Zhuang, W. Yang, Y. Xie, W. Shang, S. Su, X. Dong, J. Wu, W. Jiang, Y. Zhou, Y. Li, X. Zhou, M. Zhang, Y. Lu, Z. Pan, 2021 Involvement of lncR-30245 in Myocardial Infarction–Induced Cardiac Fibrosis Through Peroxisome Proliferator-Activated Receptor-γ–Mediated Connective Tissue Growth Factor Signalling Pathway, Zhuang, Y., T. Li, Y. Zhuang, Z. Li, W. Yang, Q. Huang, D. Li, H. Wu, G. Zhang, T. Yang, L. Zhan, Z. Pan, Y. Lu, 2019 LncRNA-H19 Drives Cardiomyocyte Senescence by Targeting miR-19a/socs1/p53 Axis, Zhuang, Y., T. Li, H. Xiao, J. Wu, S. Su, X. Dong, X. Hu, Q. Hua, J. Liu, W. Shang, J. Ju, F. Sun, Z. Pan, Y. Lu, M. Zhang, 2021 Ablation of interleukin-17 alleviated cardiac interstitial fibrosis and improved cardiac function via inhibiting long non-coding RNA-AK081284 in diabetic mice, Zhang, Y., Y.-Y. Zhang, T.-T. Li, J. Wang, Y. Jiang, Y. Zhao, X.-X. Jin, G.-L. Xue, Y. Yang, X.-F. Zhang, Y.-Y. Sun, Z.-R. Zhang, X. Gao, Z.-M. Du, Y.-J. Lu, B.-F. Yang, Z.-W. Pan, 2018

Areas of Focus

Antibody Engineering and B Cell Function

Publications

Potent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants, Li T., Han X., Gu C., Guo H., Zhang H., Wang Y., Hu C., Wang K., Liu F., Luo F., Zhang Y., Hu J., Wang W., Li S., Hao Y., Shen M., Huang J., Long Y., Song S., Wu R., Mu S., Chen Q., Gao F., Wang J., Long S., Li L., Wu Y., Gao Y., Xu W., Cai X., Qu D., Zhang Z., Zhang H., Li N., Gao Q., Zhang G., He C., Wang W., Ji X., Tang N., Yuan Z., Xie Y., Yang H., Zhang B., Huang A., Jin A., 2021
A potent neutralizing antibody provides protection against SARS-CoV-2 Omicron and Delta variants via nasal delivery, Zhang X., Zhang H., Li T., Chen S., Luo F., Zhou J., Zheng P., Song S., Wu Y., Jin T., Tang N., Jin A., Yang C., Cheng G., Gong R., Chiu S., Huang A., 2022
Structures of Omicron spike complexes and implications for neutralizing antibody development, Guo H., Gao Y., Li T., Li T., Lu Y., Zheng L., Liu Y., Yang T., Luo F., Song S., Wang W., Yang X., Nguyen H.C., Zhang H., Huang A., Jin A., Yang H., Rao Z., Ji X., 2022
A non-RBM targeted RBD specific antibody neutralizes SARS-CoV-2 inducing S1 shedding, Long Y., Song S., Luo F., Han X., Hu C., Wang Y., Li S., Wang W., Zhang H., Zhang B., Li T., Jin A., 2021
Silencing of METTL3 attenuates cardiac fibrosis induced by myocardial infarction via inhibiting the activation of cardiac fibroblasts, Li, T., Y. Zhuang, W. Yang, Y. Xie, W. Shang, S. Su, X. Dong, J. Wu, W. Jiang, Y. Zhou, Y. Li, X. Zhou, M. Zhang, Y. Lu, Z. Pan, 2021
Involvement of lncR-30245 in Myocardial Infarction–Induced Cardiac Fibrosis Through Peroxisome Proliferator-Activated Receptor-γ–Mediated Connective Tissue Growth Factor Signalling Pathway, Zhuang, Y., T. Li, Y. Zhuang, Z. Li, W. Yang, Q. Huang, D. Li, H. Wu, G. Zhang, T. Yang, L. Zhan, Z. Pan, Y. Lu, 2019
LncRNA-H19 Drives Cardiomyocyte Senescence by Targeting miR-19a/socs1/p53 Axis, Zhuang, Y., T. Li, H. Xiao, J. Wu, S. Su, X. Dong, X. Hu, Q. Hua, J. Liu, W. Shang, J. Ju, F. Sun, Z. Pan, Y. Lu, M. Zhang, 2021
Ablation of interleukin-17 alleviated cardiac interstitial fibrosis and improved cardiac function via inhibiting long non-coding RNA-AK081284 in diabetic mice, Zhang, Y., Y.-Y. Zhang, T.-T. Li, J. Wang, Y. Jiang, Y. Zhao, X.-X. Jin, G.-L. Xue, Y. Yang, X.-F. Zhang, Y.-Y. Sun, Z.-R. Zhang, X. Gao, Z.-M. Du, Y.-J. Lu, B.-F. Yang, Z.-W. Pan, 2018

Antibody Engineering B Cell Function Immunology Research Development Innovation Biotechnology Therapeutics

Jun Xu - Peking University

Li-Bin Wang - Peking University

Ling Liang - Peking University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us